Jung Eun Jang Selected Research

Jung Eun Jang Research Topics

Disease

10	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2012
4	Fibrosis (Cirrhosis) 01/2022 - 01/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 09/2012
3	Inflammation (Inflammations) 01/2019 - 03/2015
3	Coronary Stenosis (Coronary Artery Stenosis) 10/2015 - 01/2012
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
2	Alcoholic Fatty Liver 10/2021 - 10/2016
2	Hyperglycemia 01/2020 - 01/2019
2	Albuminuria 01/2019 - 06/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 06/2015
2	Insulin Resistance 01/2019 - 01/2013
2	Fatty Liver 01/2017 - 12/2011
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2019
1	Neoplasms (Cancer) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Carcinogenesis 01/2019
1	Liver Diseases (Liver Disease) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Type I Syndactyly 06/2015
1	Hypertrophy 06/2015
1	Atherosclerosis 04/2015
1	Nesidioblastosis (Nesidioblastosis of Pancreas) 04/2015
1	Insulinoma 04/2015
1	Hypoglycemia (Reactive Hypoglycemia) 04/2015
1	Pathologic Constriction (Stenosis) 12/2014
1	Obesity 09/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012
1	Choline Deficiency 12/2011

Drug/Important Bio-Agent (IBA)

4	AdiponectinIBA 01/2019 - 09/2012
3	CalciumIBA 12/2019 - 01/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2016 - 12/2011
2	LipidsIBA 01/2021 - 12/2011
2	PalmitatesIBA 01/2020 - 09/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2015
2	AdipokinesIBA 01/2019 - 04/2015
2	Insulin (Novolin)FDA Link 01/2019 - 04/2015
2	BilirubinIBA 10/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 06/2015 - 03/2015
2	C-Reactive ProteinIBA 04/2015 - 03/2015
1	InflammasomesIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	phosphatidylcholine-ceramide phosphocholine transferaseIBA 10/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	EnzymesIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Pioglitazone (Actos)FDA Link 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	ElementsIBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	CholesterolIBA 01/2017
1	PlasmalogensIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 06/2015
1	CreatinineIBA 06/2015
1	Oxidoreductases (Dehydrogenase)IBA 06/2015
1	Messenger RNA (mRNA)IBA 06/2015
1	Ceruloplasmin (Ferroxidase)IBA 06/2015
1	Hemoglobins (Hemoglobin)IBA 04/2015
1	Angiopoietin-Like Protein 2IBA 04/2015
1	AutoantibodiesIBA 04/2015
1	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2014
1	Ferritins (Ferritin)IBA 01/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2012
1	Phenobarbital (Luminal)FDA Link 01/2012
1	Choline (Choline Chloride)IBA 12/2011
1	Methionine (L-Methionine)FDA Link 12/2011

Therapy/Procedure

1	Therapeutics 01/2021
1	Pancreatectomy 04/2015